GSK has developed a new propellant technology for inhaler devices that drastically ... phase 3 testing in GSK’s asthma product Ventolin (salbutamol) next year, and according to the drugmaker ...

Several single-dose studies comparing acute bronchodilation induced by ipratropium bromide with salbutamol have shown that salbutamol was more effective than ipratropium in asthma treatment.

Excessive use of reliever inhalers for asthma is linked to a significantly increased risk of dying from the disease, a new study revealed today. Researchers found that over-use of short acting ...

medicines (inhalers and tablets) used to control and prevent asthma and breathing problems such as salbutamol (eg. Ventolin, Asmol) and terbutaline (e.g. Bricanyl) or used for other lung problems.